News & Events Archive

Monday, January 11, 2016

IMRF- VISION & RESEARCH: Researchers discover three glaucoma-related genes

IMRF- VISION & RESEARCH: Researchers discover three glaucoma-related genes NIH-funded genetics analysis of glaucoma is largest to date. An analysis funded by the National Eye Institute (NEI), part of the National Institutes of Health, has identified three genes that contribute to the most common type of glaucoma. The study increases the total number of such…

Read More

Saturday, January 9, 2016

IMRF- VISION & DIABETIC RETINOPATHY (PDR and DME): Proliferative Diabetic Retinopathy: Should New Data Change Management?

IMRF- VISION & DIABETIC RETINOPATHY (PDR and DME): Proliferative Diabetic Retinopathy: Should New Data Change Management? Beyond Standard of Care   ‪#‎blindness‬ ‪#‎Diabetes American Academy of Ophthalmology (AAO) 2015 Charles C. Wykoff, MD, PhD Disclosures | January 07, 2016 Diabetic retinopathy (DR) is a leading cause of vision loss around the world, and remains the most common cause of blindness among…

Read More

Monday, January 4, 2016

IMRF- VISION & EYE EXAMS: Glaucoma the silent thief

IMRF- VISION & EYE EXAMS: Glaucoma: the silent thief #vision #blindness By Bingham Memorial Hospital -Jan 2, 2016 Glaucoma is often called the “silent thief” of sight because half of the people affected by this eye disease do not know they have it. Undetected, glaucoma can lead to vision loss and, eventually, blindness. But vision…

Read More

Tuesday, December 22, 2015

IMRF- VISION & RESEARCH: International study reveals new genetic clues to age-related macular degeneration

IMRF- VISION & RESEARCH: International study reveals new genetic clues to age-related macular degeneration #maculardegeneration #blindnesss An international study of about 43,000 people has significantly expanded the number of genetic factors known to play a role in age-related macular degeneration (AMD), a leading cause of vision loss among people age 50 and older. Supported by…

Read More

Friday, December 18, 2015

IMRF- VISION & TECHNOLOGY: Noctura 400 Sleep Mask Helps Diabetic Patients Keep Their Eyesight

IMRF- VISION & TECHNOLOGY:  Noctura 400 Sleep Mask Helps Diabetic Patients Keep Their Eyesight… #macalaredema #diabetes #vision Diabetic retinopathy is the leading cause of blindness for adults between the ages of 20 and 64 in the United States.  As a patient’s diabetes progresses, the blood circulation worsens and the supply of oxygen to the retina is…

Read More

Thursday, December 17, 2015

IMRF- VISION & EDUCATION: What are you waiting for?

IMRF- VISION & EDUCATION:     ‪#‎AMD‬ ‪#‎vision‬ ‪#‎maculardegeneration‬ With all the available treatments for macular degeneration some people are still losing their sight, Why? The reason is ‘the window of opportunity’. Our macular degeneration/diabetic retinopathy education and vision testing tools act as an extension of your eye doctor’s office. Having a comprehensive reference and vision monitoring tool is…

Read More

Tuesday, December 1, 2015

Mini-telescope implant helps macular degeneration patients

IMRF- VISION & TECHNOLOGY:  Mini-telescope implant helps macular degeneration patients A new tool could help patients with macular degeneration recover their eyesight. Fifteen million Americans suffer from macular degeneration, making it the leading cause of blindness in this country. It usually strikes those over 50 years old. There’s no cure, but a major medical breakthrough could…

Read More

Wednesday, November 25, 2015

Association of familial macular degeneration with specific genetic markers: a case report

IMRF- VISION & RESEARCH: Association of familial macular degeneration with specific genetic markers: a case report Abstract Introduction Age-related macular degeneration is a serious visual disorder of the central retina and was recently reported to be associated with genetic background. Here we describe a genetic link to early onset age-related macular degeneration in members of…

Read More

Friday, November 20, 2015

Regulators, Researchers Seek to Advance Research on Cellular & Gene Therapies

IMRF- VISION & RESEARCH: Regulators, Researchers Seek to Advance Research on Cellular & Gene Therapies There’s renewed optimism in the biomedical research community that years of effort finally may begin to pay off for developing cutting-edge gene and cellular treatments for debilitating and life-threatening conditions. Researchers recently reported promising results from early clinical studies of…

Read More

Wednesday, November 18, 2015

Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis

IMRF- VISION & RESEARCH: Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis Abstract Background Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over 65 years old in the United States and has been associated with cardiovascular risk and decreased survival. There is conflicting data, however,…

Read More
Page 5 of 8« First...34567...Last »

FREE Macular Degeneration or Diabetic Retinopathy INFO KIT Get it now »

Become a Supporting Member Sign up now